PHANESSA JEAN: Open Payments
NPI 1215359336 · HEMPSTEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 15 payments from 7 companies in 2025. Trend: 2023 $806 · 2024 $815 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $383 |
| Otsuka America Pharmaceutical, Inc. | 2 | $245 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Alkermes, Inc. | 1 | $127 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| ViiV Healthcare Company | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, LYBALVI, UZEDY, REXULTI, ABILIFY MAINTENA, APRETUDE.
Industry payments across NY — which companies pay providers there.
